62 Results for "

rat cortex

" in MedChemExpress (MCE) Product Catalog:
Products (62)

62 Results for "rat cortex" in MCE Product Catalog:

33
33 Publications Verification
Cat. No.: HY-18731
CAS No.: 214358-33-5
1400W dihydrochloride is the dihydrochloride form of 1400W (HY-18730). 1400W is a slow, tight binding, and highly selective inducible nitric-oxide synthase (iNOS) inhibitor, with a Kd value ≤ 7 nM. 1400W inhibits iNOS induction in microglial cells, and reduces generation of NO, thereby mitigating oxidative stress and neuronal cell apoptosis in the rat cerebral cortex, and improving the spatial memory dysfunction caused by acute hypobaric hypoxia-reoxygenation .
loading...
    loading...
33
33 Publications Verification
Cat. No.: HY-18730
CAS No.: 180001-34-7
Synonyms: W1400
1400W is a slow, tight binding, and highly selective inducible nitric-oxide synthase (iNOS) inhibitor, with a Kd value ≤ 7 nM. 1400W inhibits iNOS induction in microglial cells, and reduces generation of NO, thereby mitigating oxidative stress and neuronal cell apoptosis in the rat cerebral cortex, and improving the spatial memory dysfunction caused by acute hypobaric hypoxia-reoxygenation .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B1277
CAS No.: 52-49-3
Research Areas:  

Neurological Disease

Trihexyphenidyl hydrochloride is a selective and orally active M1 muscarinic receptor antagonist with an IC50 of 3.7 nM for rat cerebral cortex M1 muscarinic receptors. Trihexyphenidyl hydrochloride modulates cholinergic activity, countering acetylcholine supersensitivity in neural pathways. Trihexyphenidyl hydrochloride improves movement disorder, inhibits McN-A-343 (HY-107648)-induced pressor responses, vagally-induced bradycardia and vasodilatation. Trihexyphenidyl hydrochloride can be used for the research of Parkinson's disease. .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-13225B
Purity:  ≥95.0%
Synonyms: RJR-2403 hemioxalate; (E)-Metanicotine hemioxalate
Target:  

nAChR

Research Areas:  

Neurological Disease

Rivanicline (RJR-2403) hemioxalate is a neuronal nicotinic receptor agonist. Rivanicline hemioxalate is highly selective for the rat brain cortex nAChRs (Ki = 26 nM, EC50 of 732 nM) and α4β2 subtype (Ki = 26 nM, EC50 = 16 μM). Rivanicline hemioxalate can significantly restore the learning impairment and cognitive dysfunction. Rivanicline hemioxalate can be used for the study of neurodegenerative diseases (such as schizophrenia or Alzheimer's disease) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101075
CAS No.: 142523-38-4
Purity:  99.52%
Target:  

Phosphatase

Research Areas:  

Others

L-690330 is a competitive inhibitor of inositol monophosphatase (IMPase) with Kis of 0.27 and 0.19 μM for recombinant human and bovine IMPase, 0.30 and 0.42 μM for human and bovine frontal cortex IMPase, respectively. L-690330 exhibits 10-fold more sensitive than mouse and rat IMPase .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101075A
CAS No.: 2930564-26-2
Purity:  ≥98.0%
Target:  

Phosphatase

Research Areas:  

Others

L-690330 hydrate is a competitive inhibitor of inositol monophosphatase (IMPase) with Kis of 0.27 and 0.19 μM for recombinant human and bovine IMPase, 0.30 and 0.42 μM for human and bovine frontal cortex IMPase, respectively. L-690330 hydrate exhibits 10-fold more sensitive than mouse and rat IMPase .
loading...
    loading...
Cat. No.: HY-17550
CAS No.: 314728-85-3
Synonyms: DM-235
Target:  

iGluR

Research Areas:  

Neurological Disease

Sunifiram (DM-235) is an ampakine-like compound and an agonist of AMPA receptor with oral activity. Sunifiram can increase the release of acetylcholine in the rat cerebral cortex and exhibits potent cognitive enhancement effects with better nootropic activity compared to piracetam (HY-B0585). Sunifiram is promising for research in neurodegenerative diseases such as mild cognitive impairment (MCI) and Alzheimer's disease (AD) .
loading...
    loading...
Cat. No.: HY-W015876
CAS No.: 7533-40-6
Synonyms: (+)-Leucinol
Target:  

Aminopeptidase

Research Areas:  

Others

L-Leucinol ((+)-Leucinol) is a competitive aminopeptidase inhibitor with a Ki value of 17 μM. As a dietary intake inhibitor, L-Leucinol reduces the basal dietary leucine intake in rats via microinjection into the rat anterior piriform cortex .
loading...
    loading...
Cat. No.: HY-101333
CAS No.: 183364-82-1
Purity:  ≥99.0%
Synonyms: (RS)-CPPG
Target:  

mGluR

Research Areas:  

Neurological Disease

CPPG ((RS)-CPPG) is a potent group II/III mGlu receptors antagonist. CPPG exhibits some selectivity (approximately 20 fold) for group III (IC50=2.2 nM) over group II (IC50=46.2 nM) mGlu receptors in the rat cerebral cortex. CPPG has weak effects at group I mGlu receptors .
loading...
    loading...
Cat. No.: HY-P1212
CAS No.: 193829-96-8
Synonyms: CST-14 (mouse, rat)
Target:  

Somatostatin Receptor

Research Areas:  

Neurological Disease

Cortistatin 14, mouse, rat (CST-14, human, rat), a neuropeptide with neuronal depressant and sleep modulating properties, can bind to all five cloned somatostatin receptors (SSTRs) and ghrelin receptor to exert its biological activities and co-exists with GABA within the cortex and hippocampus .
loading...
    loading...
Cat. No.: HY-12959A
CAS No.: 144980-77-8
Purity:  97.08%
Synonyms: BAY x 3702
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

Repinotan hydrochloride (BAY x 3702) is a potent, selective, brain-penetrant and orally active 5-HT1A receptor agonist, with Ki values of 0.19 nM (calf hippocampus), 0.25 nM (rat and human cortex), and 0.59 nM (rat hippocampus Repinotan hydrochloride has a weak affinity for other related receptors. Repinotan hydrochloride has pronounced neuroprotective effects .
loading...
    loading...
Cat. No.: HY-W795507
CAS No.: 69906-85-0
Research Areas:  

Neurological Disease

Cyanopindolol is an β3-adrenoceptor antagonist. Cyanopindolol is a potent and selective antagonist at the presynaptic serotonin autoreceptor in the rat brain cortex. Cyanopindolol has binding affinity for 5-HT1A and 5-HT1B receptor (Ki: 2.1 and 3 nM respectively) .
loading...
    loading...
Cat. No.: HY-P3801
CAS No.: 77128-69-9
Synonyms: DiMe-C7
[Glp5,(Me)Phe8,Sar9] Substance P (5-11) (DiMe-C7) is a Substance P (HY-P0201) analogue that has approximately the same effects as Substance P (HY-P0201) on neurokinin 1 receptor (NK1R) in rat brain, but with a much longer duration of action. [Glp5,(Me)Phe8,Sar9] Substance P (5-11) selectively activates dopamine metabolism in the mesencephalon and midbrain cortex of the rat brain. [Glp5,(Me)Phe8,Sar9] Substance P (5-11) also increases motor activity and induces recovery of addictive agent-seeking behavior in rats .
loading...
    loading...
Cat. No.: HY-103133
CAS No.: 1207064-61-6
Purity:  98.43%
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

WAY 208466 dihydrochloride is a potent and selective 5-HT6 receptor agonist (EC50=7.3 nM for the human 5-HT6 receptor). WAY-208466 dihydrochloride elevates cortical GABA levels in rat frontal cortex . WAY 208466 dihydrochloride exhibits antidepressant and anxiolytic-like effects .
loading...
    loading...
Cat. No.: HY-102043
CAS No.: 2095312-08-4
Research Areas:  

Neurological Disease

PDM-631 is a selective and orally active PDE2A inhibitor with blood-brain barrier penetration. PDM-631 exhibits potent inhibitory activity against human and rat recombinant PDE2A with IC50 values of 1.5 nM and 4.2 nM, respectively. PDM-631 increases cGMP levels in the rat cerebral cortex. PDM-631 can be used for the study of schizophrenia and neurodegenerative disorders .
loading...
    loading...
Cat. No.: HY-P3883
CAS No.: 81381-50-2
Target:  

Neurokinin Receptor

Research Areas:  

Neurological Disease

[DAla4] Substance P (4-11) is an analog of Substance P (HY-P0201) that inhibits the binding of 125I-Bolton Hunter-conjugated Eledoisin (HY-P0006) (IC50 of 0.5 μM) and 125I-Bolton Hunter-conjugated Substance P (IC50 of 0.15 μM) to rat brain cortex membranes .
loading...
    loading...
Cat. No.: HY-13225A
CAS No.: 15585-43-0
Synonyms: RJR-2403; (E)-Metanicotine
Target:  

nAChR

Research Areas:  

Neurological Disease

Rivanicline (RJR-2403) is a neuronal nicotinic receptor agonist. Rivanicline is highly selective for the rat brain cortex nAChRs (Ki = 26 nM, EC50 of 732 nM) and α4β2 subtype (Ki = 26 nM, EC50 = 16 μM). Rivanicline can significantly restore the learning impairment and cognitive dysfunction. Rivanicline can be used for the study of neurodegenerative diseases (such as schizophrenia or Alzheimer's disease) .
loading...
    loading...
Cat. No.: HY-B1277A
CAS No.: 144-11-6
Trihexyphenidyl is a selective and orally active M1 muscarinic receptor antagonist with an IC50 of 3.7 nM for rat cerebral cortex M1 muscarinic receptors. Trihexyphenidyl modulates cholinergic activity, countering acetylcholine supersensitivity in neural pathways. Trihexyphenidyl improves movement disorder, inhibits McN-A-343 (HY-107648)-induced pressor responses, vagally-induced bradycardia and vasodilatation. Trihexyphenidyl can be used for the research of Parkinson's disease. .
loading...
    loading...
Cat. No.: HY-12959
CAS No.: 144980-29-0
Synonyms: BAY x 3702 free base
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

Repinotan (BAY x 3702 free base) is a potent, selective, brain-penetrant and orally active 5-HT1A receptor agonist, with Ki values of 0.19 nM (calf hippocampus), 0.25 nM (rat and human cortex), and 0.59 nM (rat hippocampus). Repinotan has a weak affinity for other related receptors. Repinotan has pronounced neuroprotective effects .
loading...
    loading...
Cat. No.: HY-114753
CAS No.: 163000-63-3
Synonyms: CR-2249; XY-2401
Target:  

iGluR

Research Areas:  

Neurological Disease

Neboglamine (CR-2249; XY-2401) is a modulator for N-methyl-D-aspartate (NMDA) receptor. Neboglamine increases the levels of fos-like immunoreactivity (FLI)-positive cells in the prefrontal cortex, nucleus accumbens, and lateral septal nucleus in rat models, .restores NMDA (HY-17551) -mediated neurotransmitter release, and inhibits phencyclidine-induced hyperlocomotion .
loading...
    loading...